Original Contributions |
From the Department of Medicine (Cardiology), Vascular Biology Laboratory, University of Ottawa Heart Institute Ottawa, Ontario, Canada.
Correspondence to Edward R. O'Brien, MD, FRCP(C), FACC, Department of Medicine (Cardiology), Vascular Biology Laboratory, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario, Canada K1Y 4W7. E-mail eobrien{at}heartinst.on.ca
| Abstract |
|---|
|
|
|---|
Key Words: angiogenesis vasa vasorum remodeling restenosis
| Introduction |
|---|
|
|
|---|
Little is known about the time course of neovascularization and EC proliferation after arterial injury. This information is of potential importance because the abundance of arterial wall microvessels may be critical for the modulation of arterial repair or for adequate local delivery of therapeutic agents. This study examines the time course and degree of angiogenesis that occur during the response to arterial injury. In addition, we correlate changes in adventitial microvascularity with alterations in the dimensions of the artery wall after injury. Our results indicate that adventitial neovascularization and EC proliferation occur early after balloon injury. The loss of adventitial microvessels after single injury (SI) coincides with the development of arterial narrowing and suggests that changes in the adventitial microvasculature may be a component of arterial remodeling after angioplasty.
| Methods |
|---|
|
|
|---|
Experimental Procedure
One hour before surgery, each animal was sedated with
ketamine (25 mg/kg) intramuscularly and isoflurane (1% to 3%)
by facemask. Atropine (1 mg) was administered intramuscularly to reduce
orotracheal secretions. Intravenous access was obtained via
an ear vein, and medazolam (1 mg) was given for additional sedation.
After endotracheal intubation the animals were ventilated at an initial
rate of 15 breaths per minute. Throughout the procedure,
anesthesia was maintained with isoflurane (1% to 3%), and
the ECG, arterial blood pressure, and arterial
blood gases were monitored. A femoral artery cutdown was performed and
an arterial sheath inserted. A baseline hematocrit and
activated clotting time were obtained. Bretylium (10 mg/kg) was
given prophylactically to prevent ventricular
arrhythmias. After a 200 U/kg IV bolus of heparin was injected,
supplemental heparin was given to achieve an activated clotting
time of 300 to 350 seconds. Under fluoroscopic guidance (Cardioscope
U/Pandoras 1200S, Siemens) coronary angioplasty was performed
in the proximal segment of 1 of the 3 main coronary arteries
[ie, left anterior descending (LAD), left circumflex (LCx), and right
(RCA) coronary arteries]. The ostium of the left or right
coronary artery was cannulated with an angioplasty catheter (8F hockey
stick or 8F JR4.0, respectively). After 200 µg of
intracoronary nitroglycerin was administered,
baseline coronary angiography was performed in 2 orthogonal
views by using an ionic contrast medium (MD 76: 66% diatrizoate
meglumine and 10% diatrizoate sodium). A guide wire was advanced into
the coronary artery, and an initial injury was performed by
using standard balloon angioplasty catheters that were 3.5 to 4.5
mm in diameter. For each artery, the size of the balloon catheter was
individually selected to ensure a balloon to artery ratio of 1.3 to
1.5:1. Three balloon inflations at 10 atm for 30 seconds each
were performed with a 60-second interval between inflations.
After the last angioplasty, 200 µg of nitroglycerin
was injected into the coronary arteries and angiograms were
repeated. The arterial sheath was then removed, the femoral
artery was ligated, and the cutdown incision was closed in 2 layers.
Isoflurane anesthesia was then terminated and the pigs were
observed in the recovery room before being returned to their stalls.
Fourteen days later a second injury was performed on the
coronary artery that was originally injured, and another
coronary artery was injured for the first time by using the
same protocol. Therefore, each pig had 1 SI, 1 DI, and 1 uninjured
coronary artery. To label proliferating cells, each pig
received a 50 mg/kg IV dose of 5-bromo-2'-deoxyuridine (BrdU; Sigma
Chemical Co) dissolved in 0.9% saline 1 hour before euthanasia by KCl
overdose.
Histopathological Processing
Porcine hearts were harvested immediately after the animals were
killed and perfused with Ringers' lactate at 100 mm Hg for 10
minutes via pressure tubing seated in the ascending aorta. This
procedure was followed by perfusion-fixation with 10% neutral buffered
formalin at 100 mm Hg for 60 minutes. Hearts were immersion-fixed
in 10% neutral buffered formalin overnight and processed the following
day. Approximately 30 mm of artery from the proximal LAD, LCx, and
mid-RCA angioplasty sites were removed and processed as two 15-mm
sections. After fixation, each section was further divided into 3- to
5-mm lengths and embedded in a paraffin block. A minimum of 8 sections
from each artery was examined, and the cross section with the most
severe luminal narrowing was identified for study purposes. As well, a
section of small bowel was resected from each pig and was used as
positive control tissue for BrdU immunolabeling.
Immunocytochemistry
Immunocytochemical labeling was carried out on adjacent tissue
sections by using previously described methods.9 In brief,
this process involved deparaffinizing 5-µm tissue sections,
inhibiting endogenous peroxidase activity with 3%
H2O2, and applying the
primary antibody for 60 minutes at room temperature. Depending on the
origin of the primary antibody, a biotinylated anti-rabbit or
anti-mouse secondary antibody was applied for 30 minutes, followed by
an avidin-biotin-peroxidase complex (ABC Elite kit, Vector
Laboratories) for 30 minutes. Tris buffer (0.05 mol/L) containing the
standard peroxidase enzyme substrate 3,3'-diaminobenzidine (Sigma) with
or without NiCl2 was then added for 10 minutes at
37°C to yield a black or brown reaction product, respectively.
Hematoxylin or methyl green was used as a nuclear counterstain. An
anti-SM
-actin antibody was used to identify SMCs in the intima and
media, as well as myofibroblasts in the adventitia (1:100 titer;
Boehringer Mannheim Corp). To identify ECs, tissue slides were
predigested with 1.5N HCl for 15 minutes before an antivon
Willebrand factor (vWF) antibody (1:200 dilution; DAKO) was
added. As a negative control, PBS containing 1% BSA without the
primary antibody was used. Replicating cells were identified with an
antibody to BrdU (1:50 dilution; Boehringer Mannheim Corp).
Tissue slides were predigested with 1.5N HCl for 15 minutes at 37°C;
0.1 mol/L borax (Sigma), pH 8.5, for 5 minutes at room temperature; and
0.1% trypsin type IX for 7.5 minutes at 37°C. The primary antibody
was applied for 2 hours at 37°C. A section of porcine small bowel was
used as positive control tissue for the work-up of BrdU immunolabeling.
Two independent investigators who were blinded to the nature of tissue
sections examined all slides.
Microvessel Analysis
A modification of a previous image analysis protocol was
used to study neovascularization in these perfusion-fixed porcine
coronary arteries.10 Because the adventitia
essentially includes all tissue outside the external elastic lamina, it
is therefore difficult to objectively study without applying arbitrary
guidelines. In balloon-injured arteries, a neoadventitia (NA) that
consists of dense connective tissue and cells consistently
forms immediately outside the external elastic lamina. In contrast, the
loose connective tissue in the outer adventitia is variable in size
and is frequently disrupted during tissue dissection and processing. In
uninjured arteries the NA is small. In balloon-injured arteries, the
outer border of the NA is easily distinguished from the loose adipose
tissue and sparse cellularity found in the outer adventitia. Therefore,
the total number of microvessels in the NA, as well as the percentage
of NA occupied by microvessels, was objectively studied by 2 observers.
Tissue slides of control, SI, and DI arteries from all time points were
immunolabeled with an anti-vWF antibody. Seven control arteries and 35
balloon-injured arteries were analyzed by using the following
protocol. Each artery was divided into quadrants. Under 400x
magnification, the optical field within each quadrant that had the most
adventitial microvessels was selected for image analysis. Image
analysis was performed on coronary artery cross
sections by using digitized images projected from an Olympus BX50
microscope via a color camera (Iris CCD, Sony Corp; Bravado Truevision
Image-Capturing Software, Jandel Scientific Corp) and analyzed
using Mocha image analysis software interfaced with SigmaPlot
for Windows (both from Jandel Scientific Corp). To validate this
4-quadrant technique, we compared the results obtained with this method
to those obtained using manual counting of all adventitial
microvessels. Eight SI arteries were assessed, 2 from each
time-interval group (eg, at 3, 7, 14, and 28 days after SI). Using the
4-quadrant method and manual counting techniques, we obtained the
following series of data for each of the 4 intervals: 29.5±3.5,
35.0±2.8, 24.0±5.7, and 14.5±0.7 versus 171.0±5.6, 167.5±3.5,
110.5±9.2, and 72.0±21.2, respectively. Therefore, the relative
abundance of microvessels calculated using these 2 techniques is
similar.
In addition to counting the total number of microvessels per optical field, the perimeter of microvessels within each optical field was manually traced. For each artery the microvessel areas of the 4 quadrants were summed and divided by the total area of the optical fields for all quadrants. This quotient was expressed as a percentage by multiplying by 100, and hereafter is designated the adventitial microvascular area density (MVAD). To determine the average microvessel size for a group of arteries, we divided the total microvessel perimeter by the total microvessel number to obtain the microvessel size index (MVSI). A high index indicates that the average microvessel size is large. The MVSI was expressed in micrometers. Central arterial lumen area (LA), external elastic lamina area (EELA), and the combined area of the intima plus media (I+M) were measured for all cross sections. Because of interruptions of the internal elastic lamina after angioplasty, it was impossible to consider the intima or media as a discrete entity.
EC Proliferation
To quantify the levels of EC proliferation that accompany
adventitial microvessel angiogenesis, we used the following strategy.
As described in the Results section and the
Table
, 18 arteries had a moderate to high
increase in microvessel number and MVAD relative to uninjured arteries
(eg,
25% and
1.25%; respectively). In a separate study, we
counted the total number of cells in the adventitia as well as the
total number of adventitial cells that incorporated BrdU and determined
that in uninjured arteries, replication is either absent or very low
(ie, <0.5%; E.R.O'B. et al, unpublished data, 1998).
Therefore, to study EC proliferation in balloon-injured arteries with
moderate to high numbers of adventitial microvessels and MVAD, we
selected only those arteries with total adventitial cell proliferation
indices >0.5%. Twelve coronary arteries met these criteria, 8
of which were harvested 3 days after injury, another 3 arteries were
collected 7 days after injury, and 1 artery was harvested 14 days after
SI (Figure 1
). The entire NA of these 12
specimens was quantitatively analyzed at 400x magnification.
The total number of ECs and the total number of BrdU-immunopositive ECs
on adjacent cross sections of the same artery were manually counted.
The proliferation index (percentage of BrdU-immunopositive ECs) was
then calculated for the adventitia of each artery.
|
|
Statistical Analysis
Quantitative data were expressed as mean or median±SD. For
comparison of multigroup variables, the variance of means was
analyzed by 1-way ANOVA. If the F test results were
significant, post hoc comparisons were carried out using a Tukey test
to perform multiple pairwise comparisons. A Mann-Whitney 2-sample test
was used to compare the SI and DI groups. A Pearson correlation test
was used to correlate MVAD with LA, EELA, and I+M area. Statistical
significance was defined by a value of P<0.05. Changes in
arterial wall parameters after SI were compared
with control (uninjured) arteries. For DI arteries,
arterial wall parameters were compared with SI
arteries on day 14.
| Results |
|---|
|
|
|---|
Histomorphology
Uninjured coronary arteries were composed of a thin,
hypocellular adventitia with sparse vascularity, a modest media, and an
intima consisting of rare SMCs covered by a monolayer of ECs (Figure 2A
). One hour after SI the intima and
media were severely disrupted, usually with a full-thickness dissection
of the media in 1 or more locations. The EEL was intact in all arteries
at this interval. The adventitia was also traumatized by SI and
contained pockets of hemorrhage due to disruption of the vasa
vasorum. On days 3 and 7 after SI and DI, we consistently found
medial dissections, intramural thrombus, and a marked increase in
adventitial dense connective tissue and cells (Figure 2B
and 2C
)
|
Adventitial Microvessel Density, Number, and Size Index
Cross sections of 7 control and 35 injured porcine
coronary arteries were subjected to 4-quadrant analysis
of the MVAD, microvessel number, and MVSI (Figure 3A
and 3B
). The MVAD after SI and DI is
displayed in Figure 4A
. The MVAD for the
control arteries was 1.39±0.25% and did not vary with time of
sacrifice. The MVAD varied after SI (by ANOVA, P=0.001).
Three days after SI, the MVAD increased to 2.89±0.32%
(P=0.01 versus control). The MVAD 7 days after SI decreased
to 2.14±0.95% and was not different from that of control arteries
(P=0.25). On days 14 and 28 after SI, there was further
regression of the MVAD to levels similar to those of controls and less
than the MVAD of arteries harvested 3 days after SI (ie day 14,
1.04±0.61%, P=0.008; day 28, 0.77±0.42%,
P=0.002).
|
|
The MVAD varied after DI (by ANOVA, P<0.001). The
MVAD on days 3 and 7 after DI (3.13±0.76% and 2.65±0.63%,
respectively) was larger than the MVAD of SI arteries on day 14
(P=0.001 and P=0.006, respectively). Similar to
the course described for the SI group, the MVAD had decreased by 14 and
28 days after DI to levels near those of control arteries (1.62±0.74%
and 1.68±0.45%, respectively). The MVADs of the SI and DI arteries at
the same time points after injury were not different except for 28 days
after injury, when the MVAD of the DI group was greater than that of
the SI group (P=0.03). The changes in adventitial
microvessel number after SI followed a pattern similar to that of the
MVAD, increasing early after injury and then decreasing to levels
greater than controls by day 14 (the Table
). In contrast, the number of
adventitial microvessels at all intervals after DI was not different
than in SI arteries on day 14.
We considered that the increase in MVAD after injury may have
been due to an increase in microvessel number as well as an increase in
the size of adventitial microvessels. Therefore, we sought to determine
whether changes in vessel size also occurred in response to
arterial injury. After injury the MVSI (ratio of MV
perimeter to microvessel number; Figure 4B
) increased early after SI
and DI (by ANOVA, P=0.004 and P=<0.001,
respectively). The MVSI on days 3 and 7 after SI (73.2±18.8 and
54.7±13.6 µm, respectively) was greater than the MVSI of
control arteries (31.2±10.9 µm, P=0.002 and
P=0.012, respectively). Similarly, the MVSI on days 3 and 7
after DI (82.2±12.5 and 76.7±9.3 µm, respectively) was greater
than that of the SI arteries on day 14 (43.2±7.3 µm,
P<0.001 for both comparisons). Fourteen and 28 days after
SI, the MVSI decreased to levels that were similar to those of control
arteries. However, the MVSI 14 and 28 days after DI remained elevated
compared with the SI arteries on day 14 (58.3±10.7 µm,
P=0.031; 66.2±17.8 µm, P=0.032;
respectively).
Replication of Adventitial Microvessels
To estimate the degree of adventitial angiogenesis in the minority
of specimens that had elevated levels of neovascularization, we used
the arbitrary criteria outlined in Figure 1
. It is important to note
that 28 of the 40 arteries included in this study had low EC
proliferation indices and were not included in this detailed
analysis. The number of BrdU-immunopositive ECs and the total
number of adventitial ECs were manually counted for 12 arteries (Figure 5A
and 5B
). As shown in Figure 6
, the percentage of ECs that were
replicating varied between 3.1% and 15.1%. The majority of these
arteries were harvested 3 days after balloon injury. Indeed, 8 of 8
arteries harvested 3 days after SI or DI had elevated levels of EC
replication (12.0±3.3%). In this early-injury group the proliferation
indices of the SI and DI groups were similar (13.9±1.3% and
10.9±3.7%, respectively). Seven days after SI or DI, only 3 of 7
arteries had elevated EC proliferation indices, including 1 artery with
an EC proliferation index of 15.9% in the SI group. Only 1 of 18
arteries from the later time points after injury was analyzed,
and this artery was harvested 14 days after SI and had a proliferation
index of 10.2%. The majority of the adventitial microvessels and
proliferating ECs in this artery were located adjacent to organizing
thrombus and a large intimal/medial dissection plane.
|
|
Arterial Areas
Central Arterial LA
The LA varied after SI (by ANOVA, P<0.001; Figure 7A
). The LA on day 3 (5.89±1.62
mm2) was greater than that at all other SI time
intervals (versus control, 1.90±0.54 mm2,
P<0.001; versus day 14, 1.71±0.40
mm2, P=0.001). The LA at all intervals
after DI was similar to that of SI arteries on day 14 (by ANOVA,
P=0.12).
|
External Elastic Lamina Area
Changes in the area of the EEL were noted after both SI and DI (by
ANOVA, P<0.001 and P=0.014, respectively; Figure 7B
). For example, the EELA increased from a control value of
2.59±0.68 mm2 to 7.52±1.67
mm2 on day 3 after SI (P<0.001).
Thereafter, the EELA shrank to 3.28±1.03
mm2 by day 7 (P=0.02 versus day 3).
The EELA on day 28 after SI was also larger than control values;
however, this finding may reflect normal growth of the artery over
time. On days 14 and 28 after DI, the EELA was greater than those in SI
arteries on day 14 (P=0.001 and P=0.002,
respectively).
I+M Area
The I+M area increased after both SI and DI (by ANOVA,
P<0.001 and P=0.004, respectively). After SI
there was a progressive increase in the I+M (control, 0.69±0.17
mm2 versus day 28, 2.28±0.32
mm2, P<0.001). After DI the I+M did
not increase until day 14 and remained elevated on day 28 compared with
SI day 14 arteries (SI day 14, 1.72±0.23
mm2 versus DI day 28, 3.35±0.67
mm2, P=0.001).
Relationship Between Arterial Wall
Compartments
Accumulation of I+M area was correlated positively with expansion
of the EELA (R=0.65, P=0.00001). Moreover,
changes in the EELA were correlated with LA (R=0.72,
P=0.0000003). These data suggest that arterial
remodeling with at least partial compensatory enlargement occurred in
this model. Finally, the MVAD was also correlated positively with LA
(R=0.34, P=0.04) but not with I+M area
(R=-0.0016, P=0.99).
| Discussion |
|---|
|
|
|---|
EC Proliferation
The results of the current study indicate that adventitial EC
proliferation increases early after balloon injury. EC proliferation
was remarkably elevated 3 days after SI and DI. By 7 days after SI or
DI, elevated EC proliferation occurred less frequently. Only 1
coronary artery from a later time point after injury (14 days
after SI) had a high EC proliferation index. This artery had a major
dissection of the intima and media with disruption of the EEL and a
large organized intramural thrombus. During the angiogenic phase of
arterial repair, we observed that both the MVAD and MVSI
increased. However, at later intervals both of these
parameters regressed. Differences were noted in the
regression patterns after SI and DI. For example, the MVAD 28 days
after DI was greater than the MVAD observed at the same interval after
SI. This observation was paralleled by fact that 14 and 28 days
after DI, the size of the microvessels had not shrunk to dimensions
similar to those of control (SI day 14) arteries and that DI did not
result in a difference in adventitial microvessel number when compared
with SI arteries on day 14. The mechanisms responsible for maintaining
these microvessels after DI are unknown. Possibly, vasodilatory or
angiogenic factors (and their respective receptors) may be upregulated
by stimuli associated with injury. From our limited analysis of
EC proliferation, we failed to observe differences in replication rates
after SI and DI that might explain these differences in MVSI.
Alternatively, it is possible that differences in apoptosis
after SI and DI may exist, but, this was not specifically addressed in
this study. However, Desmouliere et al11 showed that ECs
in granulation tissue undergo apoptosis as early as 8 days
after wounding and reach a maximum apoptosis rate between days
16 and 25 after injury. This time course of EC apoptosis
parallels our observation of adventitial microvessel regression that
began between days 7 and 14 after balloon injury. Whether the
withdrawal of angiogenic growth factors induces apoptosis or
stimulation by these factors prevent apoptosis of ECs is
unknown.
Microvessel Regression and Arterial Remodeling
Little is known about the fate of arterial wall
microvessels after balloon injury, and more importantly, whether
changes in these microvessels influence the process of luminal
narrowing. Amplatz and colleagues12 examined the short-
and long-term effects of balloon injury in canine aortas. Although
their studies did not use quantitative methods to assess the abundance
of microvessels, they suggested that immediately after injury there was
a marked decrease in adventitial microvessels due to rupture, while at
later intervals capillary budding was observed. As well, Kwon et
al13 have reported preliminary data on the
arterial microcirculation of balloon-injured pig
coronary arteries using microscopic computer tomography. These
investigators found an increase in the density of vasa in arteries
subjected to balloon angioplasty but did not examine the time course of
neovascularization nor the relationship of these microvessel changes to
arterial wall dimensions. Therefore, the second aim of this
study was to relate the changes in adventitial microvascularity to the
problem of luminal narrowing. We found an increase in MVAD, MVSI, and
EC proliferation early after SI and DI. The central
arterial LA increased early after SI but not after DI. The
subsequent loss in LA after SI (but not DI) was paralleled by a
decrease in the abundance of adventitial microvessels. It is of
interest to note that after DI, the number of adventitial microvessels
did not change, nor did the central arterial LA. Moreover,
the MVAD and MVSI were greater late after DI compared with SI.
Therefore, this observation begs the question: Do arterial
wall microvessels directly or indirectly influence central
arterial lumen size? Based on the studies by Barker and
colleagues,8 occlusion of adventitial microvessels is
associated with neointimal formation, whereas restoration
of these same vessels attenuates lesion size. However, in the absence
of more definitive studies, one can only speculate with regard to
possible mechanisms by which adventitial microvessels might influence
arterial lumen size. For example, it is possible that the
microvascular endothelium is a rich source of
vasodilatory factors (eg, nitric oxide). Alternatively, a rich
arterial wall microcirculation may be protective by
providing an efficient route for the efflux of cells and noxious
factors (eg, lipoproteins) from the artery wall. Finally, we should
consider the possibility that the changes in the arterial
wall circulation are simply part of a complex form of wound healing
that occurs after injury.14 15
As described by Cohnheim16 in 1889, there are a series of events that are generic to wound healing. An initial event is the invasion of inflammatory cells, fibroblasts, and capillaries into the wound. This results in the formation of granulation tissue. With maturation of the wound, fibroblasts disappear, microvessels regress, and wound contracture occurs.17 18 In this study the changes in the arterial wall microcirculation parallel those observed in a wound. Loss of microvessels may lead to tissue hypoxia and fibrosis. Indeed, disruption of vasa vasorum of nondiseased arteries results in tissue restructuring and loss of arterial compliance.19 20 These fibrotic changes may present structural barriers that prevent adequate compensatory dilatation as neointimal mass accumulates. In this study, arterial remodeling with at least partial compensatory enlargement occurred, and the MVAD was correlated with central arterial LA. Therefore, it is intriguing to consider that adventitial microvessel regression may be a mechanism of inadequate arterial remodeling due to insufficient compensatory enlargement (or late contracture).21 22 23 24 Despite much interest in the occurrence of remodeling in human atherogenesis and restenosis, it is only now that studies are being directed toward understanding the biological mechanisms that govern this phenomenon.25 26 27 The data from this study suggest that preservation of the adventitial microcirculation after balloon angioplasty may be required to prevent excessive arterial scarring. Therefore, understanding the factors involved in EC regression is an important goal.
Finally, there are limitations of this study. Although our porcine model was designed to maximize the clinical relevance of arterial injury and repair, differences may remain. For example, the vascularity of different species is known to vary in health and disease.28 29 Second, we have not examined the neovascularization of the intima and media of these arteries and are therefore unable to comment on the potential role of these microvessels in arterial remodeling. However, because plaque neovessels are largely derived from adventitial vasa vasorum, it is likely that changes in plaque neovessels are reflected by adventitial events. Third, although the inverse relationship between microvessel abundance and arterial narrowing is of interest, more definitive studies involving agonists/antagonists of angiogenesis may help clarify the functional role of arterial wall microvessels in remodeling. Recently it has been reported that expression of vascular endothelial growth factor, a known angiogenic factor, is upregulated early after arterial injury in a rabbit model and may be instrumental in inducing arterial wall neovascularization.30 In our porcine model, we have preliminary evidence that vascular endothelial growth factor is overexpressed in the adventitia 1 hour after balloon injury (E.R.O'B. et al, unpublished data, 1998).
In summary, this is the first experimental study to provide data on adventitial angiogenesis after coronary artery angioplasty. We have demonstrated an increase in adventitial microvascularity early after balloon injury that is due to formation of new microvessels. At late intervals after SI, regression of adventitial microvessels occurs and parallels the development of central arterial luminal narrowing. In contrast, the number of adventitial microvessels and the central arterial LA do not change after DI. These data suggest that regression of adventitial microvessels may be a component of inadequate remodeling. Moreover, if strategies are to be devised to deliver therapeutic agents to the artery wall via the adventitial microcirculation, then the optimal time window is likely beyond the first day and within the first week after injury. Future studies aimed at preventing microvessel regression may be a novel means of addressing inadequate arterial remodeling after balloon injury.
| Acknowledgments |
|---|
Received August 4, 1997; accepted June 17, 1998.
| References |
|---|
|
|
|---|
2. Barger AC, Beeuwkes R, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med. 1984;310:175177.[Medline] [Order article via Infotrieve]
3. Winternitz MC, Thomas RM, LeCompte PM. The Biology of Arteriosclerosis. Springfield, Mass: Charles C. Thomas; 1938.
4. Groszek E, Grundy SM. The possible role of the arterial microcirculation in the pathogenesis of atherosclerosis. J Chronic Dis. 1980;33:679684.[Medline] [Order article via Infotrieve]
5. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993;92:945951.
6.
O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers
CE. Neovascular expression of E-selection intercellular adhesion
molecule-1, and vascular cell adhesion molecule-1 in human
atherosclerosis and their relation to intimal leukocyte
content. Circulation. 1996;93:672682.
7.
Barker SG, Talbert A, Cottam S, Baskerville PA, Martin
JF. Arterial intimal hyperplasia after occlusion of the
adventitial vasa vasorum in the pig. Arterioscler Thromb. 1993;13:7077.
8. Barker SG, Tilling LC, Miller GC, Beesley JE, Fleetwood G, Stavri GT, Baskerville PA, Martin JF. The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a `neoadventitia.' Atherosclerosis. 1994;105:131144.[Medline] [Order article via Infotrieve]
9. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1994;14:883894.
10. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 1994;145:883894.[Abstract]
11. Desmouliere A, Redard R, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995;146:5666.[Abstract]
12.
Zollikofer CL, Redha FH, Bruhlmann WF, Uhlschmid GK,
Vlodaver Z, Castaneda-Zuniga WR, Amplatz K. Acute and long-term effects
of massive balloon dilation on the aortic wall and vasa vasorum.
Radiology. 1987;164:145149.
13. Kwon HM, Sangiorgi G, Gregoire J, Camrud AR, Camrud LD, Reyes D, Beighly P, Ritman EL, Holmes DR, Schwartz RS. Vasa vasorum of balloon injured coronary arteries show marked disorganization and increased density: visualization by a microscopic 3-dimensional CT imaging technique. J Am Coll Cardiol. 1997;29:391A. Abstract.
14.
Schwartz SM, deBlois D, O'Brien ER. The intima: soil
for atherosclerosis and restenosis. Circ
Res. 1995;77:445465.
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801813.[Medline] [Order article via Infotrieve]
16. Cohnheim J. Lectures in General Pathology. London, England: The New Sydenham Society; 1889.
17. Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol. 1994;6:717725.[Medline] [Order article via Infotrieve]
18. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:16501659.[Medline] [Order article via Infotrieve]
19. Sottiurai V, Fry WJ, Stanley JC. Ultrastructural characteristics of experimental arterial medial fibroplasia induced by vasa vasorum occlusion. J Surg Res. 1978;24:169177.
20.
Stefanidis C, Vlachopoulos C, Karayannacos P, Boudoulas
H, Stratos C, Filippides T, Agapitos M, Toutouzas P. Effect of vasa
vasorum flow on structure and function of the aorta in experimental
animals. Circulation. 1995;91:26692678.
21.
Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler
LF, Wong SC, Hong MK, Kovach JA, Leon MB. Arterial
remodeling after coronary angioplasty: a serial intravascular
ultrasound study. Circulation. 1996;94:3543.
22.
Andersen HR, Maeng M, Thorwest M, Falk E. Remodeling
rather than neointimal formation explains luminal narrowing
after deep vessel wall injury: insights from a porcine
(re)stenosis model. Circulation. 1996;93:17161724.
23.
Kakuta T, Currier J, Haudenschild C, Ryan T, Faxon D.
Differences in compensatory vessel enlargement, not intimal formation,
account for restenosis after angioplasty in the
hypercholesterolemic rabbit model.
Circulation. 1994;89:28092815.
24.
Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G,
Fineberg N, Hathaway DR. Vascular injury, repair, and
restenosis after percutaneous transluminal
angioplasty in the atherosclerotic rabbit. Circulation. 1995;92:29953005.
25. Pels K, Labinaz M, O'Brien ER. Arterial wall neovascularization: potential role in atherosclerosis and restenosis. Jpn Circ J. 1997;61:893904.[Medline] [Order article via Infotrieve]
26. Schwartz SM, Murry CE, O'Brien ER. Vessel wall response to injury. Science Med. 1996;3:1221.
27.
Wong LCY, Langille BL. Developmental remodeling of the
internal elastic lamina of rabbit arteries: effect on blood flow.
Circ Res. 1996;78:799805.
28.
Wolinsky H, Glagov S. Nature of species differences in
the medial distribution of aortic vasa vasorum in mammals. Circ
Res. 1967;20:409421.
29. Schlichter J, Harris R. The vascularization of the aorta, II: a comparative study of the aortic vascularization of several species in health and disease. Am J Med Sci. 1949;218:610615.[Medline] [Order article via Infotrieve]
30. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner J. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 1997;3:879886.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J.-B. Michel, O. Thaunat, X. Houard, O. Meilhac, G. Caligiuri, and A. Nicoletti Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1259 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khan, A. Agrotis, and A. Bobik Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury Cardiovasc Res, May 1, 2007; 74(2): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Cheema, T. Hong, N. Nili, A. Segev, J. G. Moffat, K. E. Lipson, A. R. Howlett, D. W. Holdsworth, M. J. Cole, B. Qiang, et al. Adventitial Microvessel Formation After Coronary Stenting and the Effects of SU11218, a Tyrosine Kinase Inhibitor J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1067 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khurana, M. Simons, J. F. Martin, and I. C. Zachary Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal Circulation, September 20, 2005; 112(12): 1813 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pels, C. Deiner, S. E Coupland, M. Noutsias, A. P Sutter, H.-P. Schultheiss, S. Yla-Herttuala, and P. L Schwimmbeck Effect of adventitial VEGF165 gene transfer on vascular thickening after coronary artery balloon injury Cardiovasc Res, December 1, 2003; 60(3): 664 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C.M Siow, C. M Mallawaarachchi, and P. L Weissberg Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries Cardiovasc Res, July 1, 2003; 59(1): 212 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Subramanian, R. J. Kelm Jr., J. A. Polikandriotis, C. G. Orosz, and A. R. Strauch Reprogramming of vascular smooth muscle {alpha}-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant Cardiovasc Res, June 1, 2002; 54(3): 539 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-i. Okamoto, T. Couse, H. De Leon, J. Vinten-Johansen, R. B. Goodman, N. A. Scott, and J. N. Wilcox Perivascular Inflammation After Balloon Angioplasty of Porcine Coronary Arteries Circulation, October 30, 2001; 104(18): 2228 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma, M. Labinaz, J. Goldstein, H. Miller, W. J. Keon, M. Letarte, and E. O'Brien Endoglin Is Overexpressed After Arterial Injury and Is Required for Transforming Growth Factor-{beta}-Induced Inhibition of Smooth Muscle Cell Migration Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2546 - 2552. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |